Form 8-K - Current report:
SEC Accession No. 0001193125-25-116989
Filing Date
2025-05-09
Accepted
2025-05-09 17:27:47
Documents
16
Period of Report
2025-05-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d947576d8k.htm   iXBRL 8-K 23642
2 EX-5.1 d947576dex51.htm EX-5.1 9685
6 GRAPHIC g947576g0509001744930.jpg GRAPHIC 1476
7 GRAPHIC g947576g45m06.jpg GRAPHIC 11506
  Complete submission text file 0001193125-25-116989.txt   173570

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rxrx-20250509.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxrx-20250509_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxrx-20250509_pre.xml EX-101.PRE 10816
18 EXTRACTED XBRL INSTANCE DOCUMENT d947576d8k_htm.xml XML 3535
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 25931826
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)